Accenture's Strong Fundamentals Meet Slower Growth Outlook
Accenture (ACN) delivered solid FY 2025 results, but management guides for slower 2-5% growth in FY 2026 amid softer demand. ACN's strong cash flow, dividend hike, and diversified AI investments support stability, yet near-term upside is limited by cautious client spending. Valuation appears fair at 17x forward earnings, with the stock trading near the low end of its historical range and downside risk already priced in.
Accenture reports strong Q4 revenue and unveils a $865 million restructuring
Accenture beat fourth-quarter revenue estimates and unveiled a six‑month, $865 million restructuring to realign its workforce and operations for rising demand in digital and AI services.
Accenture Earnings Beat Estimates in Q4, Revenues Increase Y/Y
ACN posts earnings beat for fourth-quarter fiscal 2025, with growth across segments and strong bookings, while issuing an upbeat fiscal 2026 guidance.
Wall Street Week Ahead
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Accenture: I Need To See The AI Story Picking Up
Accenture is set to report Q4 results, with expectations of modest year-over-year growth and a sequential sales decline. ACN's AI bookings are growing but not enough to offset overall new bookings weakness and federal contract headwinds. Despite a 25% share price drop, ACN appears fairly valued, with limited upside unless AI-driven growth accelerates meaningfully.
Handicapping the Q3 Earnings Season
The Tech sector is expected to continue playing its growth role in 2025 Q3, with total earnings for the sector expected to be up +11.8% on +12.5% higher revenues.
Accenture Doesn't Deserve Such Irrational Gloom (Rating Upgrade)
Accenture is upgraded to Buy, as market pessimism has driven its valuation to decade lows despite strong fundamentals. The recent sell-off is overdone; Accenture's revenue growth is accelerating, free cash flow per share is at record highs, and EPS is rising. Concerns over U.S. government spending cuts and new bookings are overstated, with management guiding for continued revenue and earnings growth.
Wall Street Bulls Look Optimistic About Accenture (ACN): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Investors Heavily Search Accenture PLC (ACN): Here is What You Need to Know
Accenture (ACN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Accenture (ACN) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Accenture (ACN) closed at $255.88, marking a +2.71% move from the previous day.
Accenture: GenAI Growth, Reinvention Services, And Multi-Year Upside
I rate Accenture a Buy with a 2-3 year horizon, citing undervaluation versus its historical multiples and a resilient long-term business moat. Accenture's Reinvention Services reorganization and GenAI momentum are key catalysts for topline acceleration and potential multiple expansion as AI demand grows. Risks include persistent federal business setbacks, continued slowdown in bookings, and execution stumbles, which could pressure valuation and growth outlook.
Accenture: The Slump Has Gone Way Too Far
Accenture's fundamentals remain strong, with Q3 revenue growth accelerating and full-year guidance raised for key metrics despite some demand headwinds. Profitability and cash flows are robust, with operating margin improvement, double-digit EPS growth, and significant increases in both dividends and share buybacks. Valuation has become even more attractive, with the forward P/E ratio near multi-year lows and a substantial discount to the IT sector average.
